Barclays sees Fresenius Medical Care earnings hit by reimbursement pressures
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- BCS Barclays-2.9% 30d
Named in this report.
- FMS Fresenius Medical Care AG-4.5% 16d
Named in this report.
Indirectly affected
- XLF Financial Select Sector SPDR-1.5% 30d
Financial Select Sector SPDR holds the financials sector that Barclays belongs to, so it often moves with news about it.
- SAN Banco Santander, S.A-14.6% 30d
Banco Santander, S.A is a peer of Barclays in commercial banks; rivals often move on the same news.
- BBVA Banco Bilbao Vizcaya Argentaria, S.A-11.0% 30d
Banco Bilbao Vizcaya Argentaria, S.A is a peer of Barclays in commercial banks; rivals often move on the same news.
- ING ING Groep N.V
ING Groep N.V is a peer of Barclays in commercial banks; rivals often move on the same news.
- LYG Lloyds Banking Group
Lloyds Banking Group is a peer of Barclays in commercial banks; rivals often move on the same news.
- NWG NatWest Group
NatWest Group is a peer of Barclays in commercial banks; rivals often move on the same news.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Fresenius Medical Care AG belongs to, so it often moves with news about it.
- DVA DaVita+7.3% 30d
DaVita is a peer of Fresenius Medical Care AG in misc health and allied services; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| BCS | +1.30% | +6.14% | base | after close | after close | after close | after close |
| FMS | -3.38% | -0.94% | base | after close | after close | after close | after close |
| XLF | +0.66% | +3.52% | base | after close | after close | after close | after close |
| SAN | -2.51% | +2.64% | base | after close | after close | after close | after close |
| BBVA | -4.49% | +1.62% | base | after close | after close | after close | after close |
| ING | -1.32% | +3.32% | base | after close | after close | after close | after close |
| LYG | -0.69% | +3.44% | base | after close | after close | after close | after close |
| NWG | +1.15% | +6.25% | base | after close | after close | after close | after close |
| XLV | -0.10% | +2.63% | base | after close | after close | after close | after close |
| DVA | -3.00% | +0.68% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Barclays sees Fresenius Medical Care earnings hit by reimbursement pressures Investing.com
Source: Investing.com
This story
| Company | When | Move | Status |
|---|---|---|---|
| BBVA | three days earlier | +1.62% | final price |
| BBVA | five days earlier | -4.49% | final price |
| BCS | three days earlier | +6.14% | final price |
| BCS | five days earlier | +1.30% | final price |
| DVA | three days earlier | +0.68% | final price |
| DVA | five days earlier | -3.00% | final price |
| FMS | three days earlier | -0.94% | final price |
| FMS | five days earlier | -3.38% | final price |
| ING | three days earlier | +3.32% | final price |
| ING | five days earlier | -1.32% | final price |
| LYG | three days earlier | +3.44% | final price |
| LYG | five days earlier | -0.69% | final price |
| NWG | three days earlier | +6.25% | final price |
| NWG | five days earlier | +1.15% | final price |
| SAN | three days earlier | +2.64% | final price |
| SAN | five days earlier | -2.51% | final price |
| XLF | three days earlier | +3.52% | final price |
| XLF | five days earlier | +0.66% | final price |
| XLV | three days earlier | +2.63% | final price |
| XLV | five days earlier | -0.10% | final price |
Trades by members of Congress and officials in the stocks in this story
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Barclays sees Fresenius Medical Care earnings hit by reimbursement pressures” scores 12 out of 100. The score uses 1 sources.